By continuing to use Symptoma®, you confirm you accept the cookies. More on
495801 to 495900 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Epidemiological investigation of the prevalence of von Willebrand's disease.
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin.
Decreased adhesion of platelets to subendothelium in von Willebrand's disease.
The effect of ABO blood group on the diagnosis of von Willebrand disease.
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis.
Biochemistry and genetics of von Willebrand factor.
The influence of membrane skeleton on red cell deformability, membrane material properties, and shape.
Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice.
A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders.
Distribution of size and shape in populations of normal human red cells.
Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias.
Limited periods of gene expression in immunoglobulin-synthesizing cells.
Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations.
Globin synthesis in thalassaemia: an in vitro study.
Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8.
Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton.
Analysis of factors regulating erythrocyte deformability.
Partial deficiency of erythrocyte spectrin in hereditary spherocytosis.
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.
Spectrin-actin membrane skeleton of normal and abnormal red blood cells.
Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations.
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Benign liver tumors: differential diagnosis and indications for surgery.
Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.
Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects.
Distinct pathways of genomic progression to benign and malignant tumors of the liver.
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Autophagy-deficient mice develop multiple liver tumors.
GATA4 sequence variants in patients with congenital heart disease.
Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging.
Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11.
A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot.
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot.
NKX2.5 mutations in patients with tetralogy of fallot.
De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.
Discovery of swine as a host for the Reston ebolavirus.
Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes.
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
Epitopes involved in antibody-mediated protection from Ebola virus.
Ebola haemorrhagic fever.
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.
Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
Development of a preventive vaccine for Ebola virus infection in primates.
Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.
Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins.
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis.
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995.
Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.
Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN.
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.
Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.
Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.
Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation.
Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.
Aseptic meningitis in infants < 2 years of age: diagnosis and etiology.
Detection and identification of Toscana and other phleboviruses by RT-nested-PCR assays with degenerated primers.
Nested PCR for specific detection and rapid identification of human picornaviruses.
La Crosse encephalitis in children.
Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management.
Natural genetic recombination between co-circulating heterotypic enteroviruses.
Neurodevelopment and cognition in children after enterovirus 71 infection.
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.
Neuropathology of human immunodeficiency virus infection.
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.
The significance of the incidental finding of basal ganglia calcification on computed tomography.
Biosynthesis of parathyroid hormone (second of two parts).